It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
White adipose tissue (WAT) has been recognized as a fundamental and crucial organ of interest in research focusing on inflammation during obesity or aging. WAT is also proposed as a significant component of cholecalciferol and 25-hydroxyvitamin D (25(OH)D) storage, which participates in the decrease of 25(OH)D plasma levels reported during aging and obesity. In the present study, we evaluated WAT and plasma cholecalciferol and 25(OH)D content together with inflammatory status to highlight the putative relationship between vitamin D status and inflammatory process during aging alone or combined with obesity. Circulating cholecalciferol and 25(OH)D and the stored quantity of cholecalciferol and 25(OH)D in WAT were quantified in young and old mice fed a control or obesogenic diet. The inflammation was assessed by measuring plasma inflammatory cytokines, mRNA, and microRNAs inflammatory-associated in WAT. The combination of aging and obesity decreased 25(OH)D plasma levels but did not modify circulating inflammatory markers. A cumulative effect of aging and obesity was observed in WAT, with rising mRNA inflammatory cytokines, notably Ccl5 and Tnf. Interestingly, aging and obesity-associated were also characterized by increased inflammatory microRNA expression. The inflammatory parameters in WAT were negatively correlated with the plasma 25(OH)D but positively correlated with the quantity of cholecalciferol and 25(OH)D in WAT. These results support the cumulative effect of obesity and aging in aggravation of WAT inflammation and suggest that accumulation of cholecalciferol and 25(OH)D in WAT could constitute a mechanism to counteract WAT inflammation during aging and obesity.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Aix-Marseille Université, C2VN, INRAE, INSERM, Marseille, France (GRID:grid.5399.6) (ISNI:0000 0001 2176 4817); Biomeostasis, La Penne Sur Huveaune, France (GRID:grid.5399.6)
2 Aix-Marseille Université, C2VN, INRAE, INSERM, Marseille, France (GRID:grid.5399.6) (ISNI:0000 0001 2176 4817)
3 Aix-Marseille Université, C2VN, INRAE, INSERM, Marseille, France (GRID:grid.5399.6) (ISNI:0000 0001 2176 4817); PhenoMARS, CriBiom, Marseille, France (GRID:grid.5399.6)
4 Biomeostasis, La Penne Sur Huveaune, France (GRID:grid.5399.6)
5 Aix-Marseille Université, C2VN, INRAE, INSERM, Marseille, France (GRID:grid.5399.6) (ISNI:0000 0001 2176 4817); PhenoMARS, CriBiom, Marseille, France (GRID:grid.5399.6); C2VN, UMR 1260 INRAE/1263 INSERM/Aix Marseille Université, Marseille Cedex 05, France (GRID:grid.5399.6) (ISNI:0000 0001 2176 4817)